A summary of the updated report on the incidence and epidemiological trends of keratinocyte cancers in the UK 2013-2018

M Kwiatkowska^{1

2}, S Ahmed², M R Ardern-Jones³, L A Bhatti⁴, T O Bleiker^{2

5}, A Gavin⁶, S Hussain², D W Huws⁷, L Irvine¹, S M Langan⁴, G W M Millington^{2

8

9}, H Mitchell⁶, R Murphy¹⁰, L Paley¹, C M Proby¹¹, C S Thomson¹², R Thomas⁷, C Turner¹, S Vernon¹, Z C Venables^{1

2

8}

Affiliations

¹ Public Health England London Region, London, UK.
² British Association of Dermatologists, London, UK.
³ Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
⁴ London School of Hygiene and Tropical Medicine and St. John's Institute of Dermatology, London, UK.
⁵ University Hospital of Derby and Burton NHS Foundation Trust, Derby, UK.
⁶ Northern Ireland Cancer Registry, Belfast, UK.
⁷ Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales, Cardiff, UK.
⁸ Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.
⁹ Norwich Medical School, University of East Anglia, Norwich, UK.
¹⁰ Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
¹¹ Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
¹² Scottish Cancer Registry, Public Health Scotland (PHS), Edinburgh, UK.

M Kwiatkowska et al. Br J Dermatol. 2022 Feb.

. 2022 Feb;186(2):367-369.

doi: 10.1111/bjd.20764. Epub 2021 Nov 24.

¹ Public Health England London Region, London, UK.
² British Association of Dermatologists, London, UK.
³ Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
⁴ London School of Hygiene and Tropical Medicine and St. John's Institute of Dermatology, London, UK.
⁵ University Hospital of Derby and Burton NHS Foundation Trust, Derby, UK.
⁶ Northern Ireland Cancer Registry, Belfast, UK.
⁷ Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales, Cardiff, UK.
⁸ Department of Dermatology, Norfolk and Norwich University Hospital, Norwich, UK.
⁹ Norwich Medical School, University of East Anglia, Norwich, UK.
¹⁰ Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
¹¹ Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
¹² Scottish Cancer Registry, Public Health Scotland (PHS), Edinburgh, UK.

No abstract available

References

1. Public Health England National Cancer Registration Analysis Service. Cancer registration statistics: England 2018. Available at: https://www.gov.uk/government/statistics/cancer-registration-statistics-... (last accessed 2 June 2020).
1. NHS England. Waiting times for suspected and diagnosed cancer patients: 2019-20 Annual Report. Available at: https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2020/07... (last accessed 14 October 2020).
1. Venables ZC, Autier P, Nijsten T et al. Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England. JAMA Dermatol 2019; 155:298-306.
1. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166:1069-80.
1. Venables ZC, Nijsten T, Wong KF et al. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study. Br J Dermatol 2019; 181:474-82.